Site-specific proportion cured models applied to cancer registry data.
Michael Edlinger1, Hanno Ulmer, Milada Cvancarova
1Department of Medical Statistics, Informatics, and Health Economics, Innsbruck Medical University, Schöpfstraße 41/1, 6020, Innsbruck, Austria, Michael.Edlinger@i-med.ac.at.
Cancer Causes & Control : CCC
|January 21, 2014
Summary
Mixture cure models successfully estimated cancer survival rates from a small regional cancer registry. This method provides reliable survival data for various cancer types, aiding treatment monitoring.
Area of Science:
- Epidemiology
- Biostatistics
- Oncology
Background:
- Cancer registries are crucial for monitoring disease trends.
- Estimating cancer survival, especially from smaller registries, presents statistical challenges.
- Up-to-date survival data is essential for evaluating cancer treatment efficacy.
Purpose of the Study:
- To assess the applicability of proportion-cured models using data from a small regional cancer registry.
- To determine current survival levels for major cancer types in Tyrol, Austria.
Main Methods:
- Mixture cure models were employed for 25 common cancer types.
- The period approach was used to estimate the proportion cured and median survival time for fatal cases.
- Model convergence was assessed for reliability of estimates.
Main Results:
- Models converged for 14 female and 15 male cancer types.
- Cervix cancer showed the highest proportion cured (74.0%), while male pancreas cancer had the lowest (4.6%).
- Median survival for uncured cases varied, with larynx cancer (2.7 years) and acute myeloblastic leukemia (AML) (0.3 years) showing the highest and lowest, respectively.
Conclusions:
- Estimates were deemed reliable for several cancer types, including stomach, colon, lung, and AML.
- Regional cancer registry data, even from small areas, can yield valuable survival estimates.
- This methodology is advantageous for monitoring cancer treatment progress and is applicable when cancer case numbers are limited.
Related Concept Videos
01:21Cancer Survival Analysis
645
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
645
02:43Mouse Models of Cancer Study
6.4K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.4K
01:20Actuarial Approach
286
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
286